Abstract: Provided is a method of bioremediation of organic contaminated water within an annulus of an oil lubricated shaft, the method includes: (a) introducing into the annulus of said oil lubricated shaft an amount of a bioremediation combination including (i) a microbial cocktail capable of biodegrading the organic contaminants and (ii) nitrogen source, such that said bioremediation combination is brought into contact with water suspected of being contaminated in said annulus; and (b) supply into said annulus oxygen source for a time sufficient for biodegradation of at least a portion of said organic contaminants in the water within the annulus.

Abstract: Provided is a method of bioremediation of organic contaminated water within an annulus of an oil lubricated shaft, the method includes: (a) introducing into the annulus of said oil lubricated shaft an amount of a bioremediation combination including (i) a microbial cocktail capable of biodegrading the organic contaminants and (ii) nitrogen source, such that said bioremediation combination is brought into contact with water suspected of being contaminated in said annulus; and (b) supply into said annulus oxygen source for a time sufficient for biodegradation of at least a portion of said organic contaminants in the water within the annulus.

Abstract: A method of producing an antibiotic TA comprising (i) expressing in a host cell an exogenous polynucleotide sequence encoding at least one polypeptide selected from the group consisting of SEQ ID NOs: 1 and 3-19; and (ii) culturing the host cell under conditions suitable for synthesis of the antibiotic TA, thereby producing the antibiotic TA.

Abstract: The present invention relates to the field of drug delivery. More specifically, the invention relates to the preparation and use of a bacteriophage conjugated through a labile/non labile linker or directly to at least 1,000 therapeutic drug molecules such that the drug molecules are conjugated to the outer surface of the bacteriophage. The bacteriophage optionally displays on its coat a ligand that endows it with specificity towards target cells. Thus, there is provided a targeted, high-capacity drug delivery system useful for the treatment of various pathological conditions.

Abstract: There is provided DNA sequences isolated from Myxococcus xanthus partially encoding a functional portion of a polypeptide component required for the synthesis of antibiotic TA. Also provided are purified, isolated and cloned DNA sequences encoding a polypeptide component required for postmodification of antibiotic TA and encoding a gene product involved in the regulation of the biosynthesis of antibiotic TA. A purified, isolated and cloned DNA sequence having a DNA sequence (seq. ID No:2 and 20) encoding a polypeptide component required for encoding the TA gene cluster and any mutations thereof is provided. Also provided are methods of using the TA genes for combinatorial genetics and of using the TA genes encoding for synthesis and modification or regulation of antibiotic TA.

Abstract: A method of producing an antibiotic TA comprising (i) expressing in a host cell an exogenous polynucleotide sequence encoding at least one polypeptide selected from the group consisting of SEQ ID NOs: 1 and 3-19; and (ii) culturing the host cell under conditions suitable for synthesis of the antibiotic TA, thereby producing the antibiotic TA.

Abstract: A method and system for detecting or quantifying biologically effective radiation emitted from an activated wireless communication device such as a cellular phone or the antenna of a cellular phone. The method uses microorganismal cells producing a detectable response when exposed to biologically effective radiation. The device is placed a predetermined distance from microorganismal cells and then activated for a predetermined amount of time. At the end of the predetermined amount of time, it is determined whether the response was produced in the cells. Production of the response indicates that the device emitted biologically effective radiation.